BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11544387)

  • 21. The effects of household and workplace smoking restrictions on quitting behaviours.
    Farkas AJ; Gilpin EA; Distefan JM; Pierce JP
    Tob Control; 1999; 8(3):261-5. PubMed ID: 10599569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Voice disorders in the workplace: productivity in spasmodic dysphonia and the impact of botulinum toxin.
    Meyer TK; Hu A; Hillel AD
    Laryngoscope; 2013 Nov; 123 Suppl 6():S1-14. PubMed ID: 23818277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of the nicotine skin patch by smokers in 20 communities in the United States, 1992-1993.
    Cummings KM; Hyland A; Ockene JK; Hymowitz N; Manley M
    Tob Control; 1997; 6 Suppl 2(Suppl 2):S63-70. PubMed ID: 9583655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Burden of smoking among adults with COPD, chronic bronchitis, and emphysema in urban China.
    Goren A; Gupta S; Dong P; Feng Y; Chen C; Liu D
    Int J Clin Pract; 2015 Sep; 69(9):1015-28. PubMed ID: 26136208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic Evaluation of Combining Pharmaco- and Behavioral Therapies for Smoking Cessation in an Occupational Medicine Setting.
    Rejas-Gutiérrez J; López-Ibáñez de Aldecoa A; Casasola M; Varela P; Quesada S; Olive V; Arriaza E
    J Occup Environ Med; 2019 Apr; 61(4):318-327. PubMed ID: 30688765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling the impact of enhanced depression treatment on workplace functioning and costs: a cost-benefit approach.
    Lo Sasso AT; Rost K; Beck A
    Med Care; 2006 Apr; 44(4):352-8. PubMed ID: 16565636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smoking after the age of 65 years: a qualitative exploration of older current and former smokers' views on smoking, stopping smoking, and smoking cessation resources and services.
    Kerr S; Watson H; Tolson D; Lough M; Brown M
    Health Soc Care Community; 2006 Nov; 14(6):572-82. PubMed ID: 17059499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of Heart Failure and Death After Prolonged Smoking Cessation: Role of Amount and Duration of Prior Smoking.
    Ahmed AA; Patel K; Nyaku MA; Kheirbek RE; Bittner V; Fonarow GC; Filippatos GS; Morgan CJ; Aban IB; Mujib M; Desai RV; Allman RM; White M; Deedwania P; Howard G; Bonow RO; Fletcher RD; Aronow WS; Ahmed A
    Circ Heart Fail; 2015 Jul; 8(4):694-701. PubMed ID: 26038535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Smoking in a public health agency: its relationship to sick leave and other life-style behavior.
    Gabel HD; Colley-Niemeyer B
    South Med J; 1990 Jan; 83(1):13-7. PubMed ID: 2300829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding limitations in at-work productivity in patients with active ankylosing spondylitis: the role of work-related contextual factors.
    Boonen A; Boone C; Albert A; Mielants H
    J Rheumatol; 2015 Jan; 42(1):93-100. PubMed ID: 25362661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impacts of a smoking cessation benefit among employed populations.
    Halpern MT; Dirani R; Schmier JK
    J Occup Environ Med; 2007 Jan; 49(1):11-21. PubMed ID: 17215709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Smoking-related costs among 25 to 59 year-old males in a 19-year individual follow-up.
    Kiiskinen U; Vartiainen E; Puska P; Pekurinen M
    Eur J Public Health; 2002 Jun; 12(2):145-51. PubMed ID: 12073754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The opinions of employees about smoking in the workplace].
    Osuchowski F; Penar-Zadarko B; Bukała-Siedlecka I; Binkowska-Bury M
    Przegl Lek; 2009; 66(10):801-4. PubMed ID: 20301940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perceived workplace health support is associated with employee productivity.
    Chen L; Hannon PA; Laing SS; Kohn MJ; Clark K; Pritchard S; Harris JR
    Am J Health Promot; 2015; 29(3):139-46. PubMed ID: 25559250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Cross-sectional Examination of What Smokers Perceive to be Important and Their Willingness to Pay for Tobacco Cessation Medications.
    Dube SR; Pesko MF; Xu X
    J Public Health Manag Pract; 2016; 22(1):48-56. PubMed ID: 26594936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimating the public economic consequences of introducing varenicline smoking cessation therapy in South Korea using a fiscal analytic framework.
    Connolly MP; Baker CL; Kotsopoulos N
    J Med Econ; 2018 Jun; 21(6):571-576. PubMed ID: 29376747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Environmental tobacco smoke exposure in the home and worksite and health effects in adults: results from the 1991 National Health Interview Survey.
    Mannino DM; Siegel M; Rose D; Nkuchia J; Etzel R
    Tob Control; 1997; 6(4):296-305. PubMed ID: 9583627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversal of Smoking Effects on Chronic Rhinosinusitis after Smoking Cessation.
    Phillips KM; Hoehle L; Bergmark RW; Caradonna DS; Gray ST; Sedaghat AR
    Otolaryngol Head Neck Surg; 2017 Oct; 157(4):737-742. PubMed ID: 28699423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in health care costs before and after smoking cessation.
    Fishman PA; Thompson EE; Merikle E; Curry SJ
    Nicotine Tob Res; 2006 Jun; 8(3):393-401. PubMed ID: 16801297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smoking and absence from work: systematic review and meta-analysis of occupational studies.
    Weng SF; Ali S; Leonardi-Bee J
    Addiction; 2013 Feb; 108(2):307-19. PubMed ID: 23078132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.